IsoRay, Inc. (DE) (ISR): Price and Financial Metrics
ISR Price/Volume Stats
| Current price | $0.38 | 52-week high | $0.45 |
| Prev. close | $0.38 | 52-week low | $0.19 |
| Day low | $0.36 | Volume | 145,000 |
| Day high | $0.39 | Avg. volume | 290,697 |
| 50-day MA | $0.32 | Dividend yield | N/A |
| 200-day MA | $0.33 | Market Cap | 54.57M |
ISR Stock Price Chart Interactive Chart >
IsoRay, Inc. (DE) (ISR) Company Bio
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company produces CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers, as well as ocular melanoma. It sells its products to facilities or physician practices that utilize multiple surgical facilities at which primarily prostate brachytherapy procedures are performed. Isoray, Inc. was founded in 1998 and is headquartered in Richland, Washington.
ISR Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ISR Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | 36.20% |
| 5-year | -45.95% |
| YTD | N/A |
| 2024 | N/A |
| 2023 | 0.00% |
| 2022 | -36.28% |
| 2021 | -13.82% |
| 2020 | -27.93% |